CrushSCI.com
Journal Selection & Manuscript Polishing Services
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q2
91.9Average days
98Median days
34Fastest days
157Longest days
1482025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

102 days

Investigating PXR ( NR1I2) genetic polymorphisms as possible determinants of the magnitude of the clindamycin–rifampicin pharmacokinetic interaction

AuthorsValérie Zeller; Estelle Lu; Léo Mimram; Kamilia Brinis; Younes Kerroumi; Armelle Arnoux; Marie-Anne Loriot; Céline Narjoz; Vincent Jullien

Affiliations1. Centre de Référence des Infections Ostéo-Articulaires Complexes, Groupe Hospitalier Diaconesses–Croix Saint-Simon, Paris, France; 2. Service de Médecine Interne et Infectiologie, Groupe Hospitalier Diaconesse–Croix Saint-Simon, Paris, France; 3. Unité de Recherche Clinique, Hôpital Européen Georges-Pompidou, Assistance Publique–Hôpitaux de Paris, Paris, France; 4. Université Sorbonne Paris Nord, Infection, Antimicrobien, Modélisation, Evolution, IAME, F-93000, Bobigny, France; Université Paris Cité, F-75018, Paris, France; INSERM, U 1137, F-75018, Paris, France; 5. Service de Biochimie, Hôpital Européen Georges-Pompidou, Assistance Publique–Hôpitaux de Paris, Paris, France; 6. Unité Fonctionnelle de Pharmacologie, GHU Paris Seine Saint-Denis, Assistance Publique–Hôpitaux de Paris, Université Sorbonne Paris Nord, Bondy, France; 7. Unité Fonctionnelle de Pharmacologie, Hôpital Jean-Verdier, Bondy, France

Source PDF DOI Publisher page
75 days

SGLT2 inhibitors and secondary polycythemia: a systematic review and meta-analysis of hematologic effects in patients with type 2 diabetes

AuthorsElrazi Awadelkarim Hamid Ali; Marrita Rabadi; Ruba Adel Aweer; Eihab Subahi; Elabbass A Abdelmahmuod; Awni Alshurafa; Mohammed Abdulgayoom; Mohamed Fawzi Mudarres; Usra Elshaikh; Abdulrahman Al-Mashdali; Shehab Mohamed

Affiliations1. Department of Hematology and Medical Oncology, University of Louisville, UofL Health - Brown Cancer Center , Louisville, USA; 2. College of Medicine, QU Health, Qatar University, Doha, Qatar; 3. Department of internal Medicine, University of Toledo, Toledo, USA; 4. Hamad Medical Corporation, Doha, Qatar; 5. National Center for Cancer Care and Research, Doha, Qatar; 6. Mercy Hospital, St louis, USA; 7. Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar

Source PDF DOI Publisher page
157 days

The safety and efficacy of peri-operative nefopam for analgesia in hip and knee arthroplasty: A systematic review and meta-analysis

AuthorsElizabeth Adeyeye; Ruth Adeyeye; Osayere Joseph-Osahon; Chukwudubem Anibueze; Ikenna Ibeanusi; Temidayo Osunronbi

Affiliations1. Melanin Medics Research Network, Luton, UK; 2. Imperial College School of Medicine, Imperial College London, London, UK; 3. University College London Medical School, University College London, London, UK; 4. Trauma and Orthopaedics Department, Lister Hospital, East & North Hertfordshire NHS Trust, Stevenage, UK; 5. Department of Clinical Oncology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK

Source PDF DOI Publisher page
34 days

Does the drug accelerate the decline, or the decline invite the drug? Reverse causation in studies of inappropriate medications and dementia progression

AuthorsWenling Chen

Affiliations1. Department of Geriatric Psychiatry, Lishui Second People’s Hospital, Zhejiang, China

Source PDF DOI Publisher page
89 days

The “obesity paradox” in dosing: a comprehensive analytical review of cockcroft–gault versus CKD-EPI for predicting clearance of narrow-therapeutic-index drugs in patients with BMI > 40 kg/m²

AuthorsArbind Kumar Choudhary

Affiliations1. ¹Department of Pharmacology, Government Erode Medical College and Hospital, Erode, India

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.